SCHEMBL13653517

SCHEMBL13653517

CCOP(=O)(CC(=O)Nc1ccccc1O)OCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 5/20 0.51
▸ RAB9A P51151 5/20 0.51
▸ MAPT P10636 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ PKM P14618 1/20 0.51
▸ KDM1A O60341 1/20 0.46
▸ NPC1 O15118 5/20 0.45
▸ TP53 P04637 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12497355 0.85 KDM4E (0.47) GAARAB9AMAPTKMT2AMAPK1
SCHEMBL4817806 0.85 HPGD (0.53) RAB9AMAPTMAPK1NPC1LMNA
SCHEMBL10952765 0.80 NPSR1 (0.53) GAARAB9AMAPTMAPK1NPC1
SCHEMBL28463477 0.80 GAA (0.48) GAAMAPTKMT2AMEN1LMNA
SCHEMBL15483137 0.80 LMNA (0.41) GAAKMT2AMAPK1LMNAHTT
SCHEMBL10579572 0.77 HDAC1 (0.54) GAARAB9AMAPTKMT2AMEN1
SCHEMBL13653001 0.76 ALDH1A1 (0.51) MAPTKMT2AMEN1MAPK1LMNA
SCHEMBL16766556 0.76 PTK2 (0.38) GAAMAPTKMT2AMAPK1HTT
SCHEMBL28046922 0.76 GAA (0.44) GAAMAPTKMT2AMEN1MAPK1
SCHEMBL860003 0.76 KDM1A (0.57) GAARAB9AMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247488-A1 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS CANNIZZARO CARINA 2009-10-01 — — US disclosed
US-20090247488-A1 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS CANNIZZARO CARINA 2009-10-01 — — US disclosed
US-7432261-B2 Anti-inflammatory phosphonate compounds GILEAD SCIENCES, INC. (US) 2008-10-07 — — US disclosed
US-7432261-B2 Anti-inflammatory phosphonate compounds GILEAD SCIENCES, INC. (US) 2008-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247488-A1 ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS PHOSPHO1, TNF, PTGES GAA 1850/4885RAB9A 3453/4885MAPT 2574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback